Anxiety and depression stand as prevalent mental health disorders on a global scale, impacting countless individuals across all walks of life. Anxiety presents as a persistent state of apprehension, fear, and worry, often accompanied by physical manifestations like increased heart rate and trembling. Its various forms encompass generalized anxiety disorder, panic disorder, social anxiety disorder, and specific phobias. Conversely, depression manifests through enduring feelings of sadness, hopelessness, and disinterest in once-enjoyable activities, alongside physical symptoms such as changes in appetite and sleep patterns, fatigue, and difficulty concentrating. Major depressive disorder and persistent depressive disorder represent common iterations, significantly impeding daily functioning and life quality. Frequently, individuals grapple with both anxiety and depression concurrently, termed comorbid anxiety-depression. The etiology of these conditions is intricate, involving genetic predispositions, environmental stressors, and psychological factors. Traumatic experiences, chronic stress, neurotransmitter imbalances, and genetic predispositions all contribute to their development. Treatment strategies typically encompass a blend of therapy, medication, and lifestyle adjustments. Cognitive-behavioral therapy (CBT) and other psychotherapeutic modalities empower individuals to comprehend and regulate their thoughts and behaviors. Pharmacological interventions, including antidepressants and anti-anxiety medications, serve to mitigate symptoms. Furthermore, lifestyle modifications such as regular exercise, balanced nutrition, ample sleep, and stress management techniques constitute integral facets of a holistic treatment regimen. Timely intervention and sustained support are paramount in effectively managing anxiety and depression, thereby fostering improved overall well-being.
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Modeling early neurologic trajectories after elevated leg positioning (ELP): A secondary analysis of the LEG-UP randomized feasibility study
Kayode Ahmed, The University of Texas MD Anderson Cancer Center, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Prescribing joy: The importance of integrating memory cafes into dementia care
Saul Beaumont, Massachusetts Advisory Council on Alzheimer's Disease and All Other Dementias, United States